Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study.

Jelena Pavlović Maryam Kavousi M Arfan Ikram Maarten J G Leening

Atherosclerosis

Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Cardiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address:

Published: April 2020

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.atherosclerosis.2020.02.020	DOI Listing

Publication Analysis

Top Keywords

updated treatment

treatment thresholds

thresholds 2019

2019 esc/eas

esc/eas dyslipidaemia

dyslipidaemia guidelines

guidelines expand

expand indications

indications statin

statin primary

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!